caa a22 4500 475773438 CHVBK 20180406123624.0 cr unu---uuuuu 170329e20000301xx s 000 0 eng 10.1023/A:1007152016341 doi (NATIONALLICENCE)springer-10.1023/A:1007152016341 Adjuvant chemotherapy for non-organ confined disease after radical cystectomy [Elektronische Daten] [Ali Tekin, Haluk Özen] Of 50 patients with pT3b, pT4 and/or pN+ disease after cystectomy, 27 were administered adjuvant four cycles of cisplatin, methotrexate and vinblastine (CMV) and 23 were followed expectantly (no-treatment group).Median follow-up was 14 months in CMV group and 11 months in no-treatment group. Median recurrence-free survival was 21 months in CMV group and 17 months in no-treatment group (p = 0.573). Median overallsurvival was 41+ months in CMV group and 84+ months in no-treatmentgroup, respectively (p = 0.501). In our experience, adjuvant chemotherapy after cystectomy seemed not to provide a survival advantage. Kluwer Academic Publishers, 2000 Bladder neoplasms nationallicence Chemotherapy nationallicence Prognosis nationallicence Tekin Ali Department of Urology, Hacettepe University, Ankara, Turkey aut Özen Haluk Department of Urology, Hacettepe University, Ankara, Turkey aut International Urology and Nephrology Kluwer Academic Publishers 32/1(2000-03-01), 59-62 0301-1623 32:1<59 2000 32 11255 https://doi.org/10.1023/A:1007152016341 text/html Onlinezugriff via DOI 1 research-article jats NATIONALLICENCE 856 40 https://doi.org/10.1023/A:1007152016341 text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Tekin Ali Department of Urology, Hacettepe University, Ankara, Turkey aut NATIONALLICENCE 700 1- Özen Haluk Department of Urology, Hacettepe University, Ankara, Turkey aut NATIONALLICENCE 773 0- International Urology and Nephrology Kluwer Academic Publishers 32/1(2000-03-01), 59-62 0301-1623 32:1<59 2000 32 11255 Metadata rights reserved Springer special CC-BY-NC licence nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-springer